STAT+: Pharmalittle: FDA advisers recommend approval of controversial ALS drug; judge rules against coverage of HIV prevention drugs
An independent panel of advisers to the FDA recommended the approval of a new drug to treat people with ALS developed by Amylyx Pharmaceuticals.
Rise and shine, everyone, another busy day is on the way. We can tell by the sound of traffic outside our window and the steady
